Vanta Bioscience Ltd IPO

Vanta Bioscience Limited (VBS) is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele. Company is headquartered in the USA and operating out of Chennai, India (Research Facility). VBS has 56,000 sq. ft. state of art facilities for conducting various pre-clinical studies and allied research.

Date of establishment: Vanta Bioscience Limited was incorporated in 1995

Product & Service Offering: Company provides safety assessment services for client. They also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.

Promoters of Vanta Bioscience: The promoters of the company are:

1. Mohan Krishna Mulakala,
2. Dopesh Raja Mulakala,
3. Dr Vyasmurti Madhavrao Shingatgeri,
4. Dr. Soumya Simhadri,
5. Shravan Chintapatla,
6. Karishma Mulakala,
7. Sajan Kiran Mulakala,
8. Pradeep Chowdary and
9. Dr. Chandrasekhar Rao Simhadri

Customer segment: The company offers its services to clients in Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. 

Objects of the Issue: The objects of the Offer is to:-
-     To meet additional Working Capital Requirement
-     To meet General Corporate Purpose